We use cookies for a better user experience. Read our Privacy Policy

I Agree

Liquid Biopsy Market Outlook, 2018-2026

Liquid Biopsy Market (Application - Oncology, NIPT, Transplant Diagnostics; Circulating Biomarker - Circulating Tumor Cells (CTC), Free Nucleic Acid, Extracellular Vesicles; End use - Hospitals, Reference Laboratories, Academic and Research Institutes) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Liquid Biopsy Market – Snapshot

 Liquid biopsy is a minimally invasive test to assess cancer genetic status based on the analysis of circulating biomarkers that are present in the plasma component of the blood. Liquid biopsies are majorly utilized in the field of oncology. Liquid biopsy can improve and/or resolve several inherent problems found with current cancer treatment, enabling early cancer detection, mutation detection, tumor monitoring during treatment, and recurrence monitoring via a non-invasive blood draw. In addition to being non-invasive, liquid biopsies have the potential to detect cancer before substantial tumor formation, assess multiple mutations within the tumor (reducing heterogeneity concerns), quantitatively monitor treatment progress, and identify new mutations as they emerge as well as monitor for recurrence to detect cancer before imaging-detectable tumor formation or metastasis. In addition to oncology, liquid biopsies are applicable in prenatal testing and transplant care.

liquid biopsy market

The global liquid biopsy market was valued at around US$ 3,883.2 Mn in 2017 and is anticipated to reach US$ 9071.7 Mn by 2026, expanding at a CAGR of 10.1% from 2018 to 2026. Rising prevalence of cancer, increasing applications of liquid biopsy, and intensive research activities being performed to determine the efficacy of liquid biopsy over other diagnostic tests are some factors that are estimated to propel the market during the forecast period.

Presently, R&D on cancer diagnosis is primarily focused toward liquid biopsy. Market players and research institutes are conducting extensive clinical trials to develop highly sensitive liquid biopsy platform. In May 2018, Grail, a U.S.-based biotechnology company, raised US$ 1 Bn in VC funding and embarked on a 120,000-patient study for early breast cancer detection. In January 2018, researchers at Johns Hopkins developed a test called CancerSEEK, which is a non-invasive multianalyte test that analyzes levels of eight cancer proteins and presence of cancer gene mutation in circulating DNA in the blood. The test included more than 1000 patients with nonmetastatic, stages I to III cancers of the ovary, stomach, liver, pancreas, esophagus, lungs, colorectum, and breast. Extensive research on liquid biopsy aimed at promoting early diagnosis in cancer is likely to drive the market for during the forecast period

The liquid biopsy market has been segmented based on application, circulating biomarker, end-user, and region. In terms of application, the oncology segment is estimated to account for a major share of the market. According to the World Health Organization (WHO), cancer accounted for 8.8 million deaths, in 2015. Globally, 1 in 6 deaths is due to cancer. Hence, rise in prevalence of cancer and the need of personalized medicine are expected to augment the segment. Based on circulating biomarkers, the free nucleic acid segment held a major share of the market in 2017. The segment is likely to expand at a considerable growth rate, as compared to other circulating biomarkers, during the forecast period. Introduction of next-generation sequencing and improvements in front-end sample preparation and back-end bioinformatics have led to significant improvement in the sensitivity of cell-free DNA assay, which in turn is driving the segment.

In terms of region, the global liquid biopsy market has been categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Developed regions such as North America and Europe accounted for a leading share of the global liquid biopsy market in 2017. The large base of biopharmaceutical companies and research and academic institutes in these regions has contributed to the leading share of these regions. Moreover, increasing prevalence of cancer and rising geriatric population are further driving the liquid biopsy market in these regions. The market in Asia Pacific is projected to expand at an exponential growth rate, owing to rapidly improving health care facilities in countries such as India, China, South Korea, and Malaysia. China dominated the liquid biopsy market in Asia Pacific, whereas the market in India is anticipated to expand at a significant growth rate during the forecast period. Furthermore, increase in investment by leading market players and hospitals providers is expected to fuel the market in the region. These factors are likely to drive the demand for liquid biopsy in the near future. The market in Latin America and Middle East & Africa is projected to expand at a steady pace during the forecast period.

Prominent players operating in the global liquid biopsy market include Biocept, Inc., MDxHealth, Myriad Genetics, Inc., Bio-Rad Laboratories, QIAGEN, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Genomic Health, Inc., and Illumina, Inc.

The global liquid biopsy market has been segmented as follows:

Application

  • Oncology
  • NIPT
  • Transplant Diagnostics
  • Others

Circulating Biomarker

  • Circulating Tumor Cells (CTC)
  • Free Nucleic Acid
  • Extracellular vesicles/Exosomes

End-user

  • Hospitals
  • Reference Laboratories
  • Academic and Research Institutes
  • Others

Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • Australia & New Zealand
    • Japan
    • China
    • India
    • Rest of Asia pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Israel
    • Rest of Middle East & Africa
Liquid Biopsy Market Outlook, 2018-2026

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Section 1 Preface

1.1 Report Scope and Market Segmentation
1.2 Research Highlights

Section 2 Assumptions and Research Methodology
2.1 Assumptions
2.2 Research Methodology

Section 3 Executive Summary
3.1 Global Liquid Biopsy Market Snapshot
3.2 Market Share Analysis by Region, 2017

Section 4 Market Overview
4.1 Liquid Biopsy Market Taxonomy
4.2 Global Liquid Biopsy Market Size (US$ Mn) Forecast, 2016–2026
4.3 Global Liquid Biopsy Market: Market Outlook
4.4 Key Industry Events

Section 5 Market Dynamics
5.1 Drivers and Restraints Snapshot Analysis
5.2 Drivers
5.3 Restraints
5.4 Key Trends
5.5 Comparison of Liquid Biopsy and Tissue Biopsy: Practical Considerations
5.6 Liquid Biopsy Workflow
5.7 Cancer Epidemiology (Region wise)
5.8 Healthcare Overview
5.9. Comparison of Different Classes of Circulating Biomarkers and their Potential for Liquid Biopsy

Section 6 Liquid Biopsy Market Analysis, by Application
6.1 Key Findings
6.2 Introduction
6.3 Global Liquid Biopsy Market Value Share Analysis, by Application
6.4 Global Liquid Biopsy Market Forecast, by Application
    6.4.1 Global Liquid Biopsy Market Value Share Analysis, by Oncology
           6.4.1.1  Global Liquid Biopsy Market Forecast, by Oncology
6.5 Global Liquid Biopsy Market Forecast, by Application
    6.5.1 Oncology
    6.5.2 NIPT
    6.5.3 Transplant Diagnostics
    6.5.4 Others
6.6 Global Liquid Biopsy Market Attractiveness Analysis, by Application

Section 7 Global Liquid Biopsy Market Analysis, by Circulating Biomarkers
7.1 Key Findings
7.2 Introduction
7.3 Global Liquid Biopsy Market Value Share Analysis, by Circulating Biomarkers
7.4 Global Liquid Biopsy Market Forecast, by Circulating Biomarkers
    7.4.1 Circulating Tumor Cells (CTC)
    7.4.2 Free Nucleic Acid
    7.4.3 Exosomes
7.5 Global Liquid Biopsy Market Attractiveness Analysis, by Circulating Biomarkers

Section 8 Global Liquid Biopsy Market Analysis, by End-user
8.1 Introduction
8.2 Global Liquid Biopsy Market Value Share Analysis, by End-user
8.3 Global Liquid Biopsy Market Forecast, by End-user
    8.3.1 Hospitals
    8.3.2 Reference Laboratories
    8.3.3 Academic and research institutes
    8.3.4 Others
8.4 Global Liquid Biopsy Market Attractiveness Analysis, by Circulating Biomarkers

Section 9 Global Liquid Biopsy Market Analysis, by Region
9.1 Global Liquid Biopsy Market Value Share Analysis, by Region
9.2 Global Liquid Biopsy Market Forecast, by Region
9.3 Global Liquid Biopsy Market Attractiveness Analysis, by Region

Section 10 North America Liquid Biopsy Market Analysis
10.1 North America Liquid Biopsy Market Overview
10.2 North America Liquid Biopsy Market Value Share Analysis, by Application
10.3 North America Liquid Biopsy Market Forecast, by Application
    10.3.1 North America Liquid Biopsy Market Forecast, by Oncology
10.4 North America Liquid Biopsy Market Value Share Analysis, by Circulating Biomarker
10.5 North America Liquid Biopsy Market Forecast, by Circulating Biomarkers
10.6 North America Liquid Biopsy Market Value Share Analysis, by End-user
10.7 North America Liquid Biopsy Market Forecast, by End-user
10.8 North America Liquid Biopsy Market Value Share Analysis, by Country
10.9 North America Liquid Biopsy Market Forecast, by Country
    10.9.1 U.S.
    10.9.2 Canada
10.10 North America Liquid Biopsy Market Attractiveness Analysis
    10.10.1 By Country
    10.10.2 By Application
    10.10.3 By Circulating Biomarker
    10.10.4 By End-user

Section 11 Europe Liquid Biopsy Market Analysis
11.1 Europe Liquid Biopsy Market Overview
11.2 Europe Liquid Biopsy Market Value Share Analysis, by Application
11.3 Europe Liquid Biopsy Market Forecast, by Application
    11.3.1 Europe Liquid Biopsy Market Forecast, by Oncology
11.4 Europe Liquid Biopsy Market Value Share Analysis, by Circulating Biomarker
11.5 Europe Liquid Biopsy Market Forecast, by Circulating Biomarkers
11.6 Europe Liquid Biopsy Market Value Share Analysis, by End-user
11.7 Europe Liquid Biopsy Market Forecast, by End-user
11.8 Europe Liquid Biopsy Market Value Share Analysis, by Country
11.9 Europe Liquid Biopsy Market Forecast, by Country
    11.9.1 Germany
    11.9.2 U.K.
    11.9.3 France
    11.9.4 Spain
    11.9.5 Italy
    11.9.6 Rest of Europe
11.10 Europe Liquid Biopsy Market Attractiveness Analysis
    11.10.1 By Country
    11.10.2 By Application
    11.10.3 By Circulating Biomarker
    11.10.4 By End-user

Section 12 Asia Pacific Liquid Biopsy Market Analysis
12.1 Asia Pacific Liquid Biopsy Market Overview
12.2 Asia Pacific Liquid Biopsy Market Value Share Analysis, by Application
12.3 Asia Pacific Liquid Biopsy Market Forecast, by Application
    12.3.1 Asia Pacific Liquid Biopsy Market Forecast, by Oncology
12.4 Asia Pacific Liquid Biopsy Market Value Share Analysis, by Circulating Biomarker
12.5 Asia Pacific Liquid Biopsy Market Forecast, by Circulating Biomarkers
12.6 Asia Pacific Liquid Biopsy Market Value Share Analysis, by End-user
12.7 Asia Pacific Liquid Biopsy Market Forecast, by End-user
12.8 Asia Pacific Liquid Biopsy Market Value Share Analysis, by Country
12.9 Asia Pacific Liquid Biopsy Market Forecast, by Country
    12.9.1 China
    12.9.2 Japan
    12.9.3 India
    12.9.4 Australia & New Zealand
    12.9.5 Rest of APAC
12.10 Asia Pacific Liquid Biopsy Market Attractiveness Analysis
    12.10.1 By Country
    12.10.2 By Application
    12.10.3 By Circulating Biomarker
    12.10.4 By End-user

Section 13 Latin America Liquid Biopsy Market Analysis
13.1 Latin America Liquid Biopsy Market Overview
13.2 Latin America Liquid Biopsy Market Value Share Analysis, by Application
13.3 Latin America Liquid Biopsy Market Forecast, by Application
    13.3.1 Latin America Liquid Biopsy Market Forecast, by Oncology
13.4 Latin America Liquid Biopsy Market Value Share Analysis, by Circulating Biomarker
13.5 Latin America Liquid Biopsy Market Forecast, by Circulating Biomarkers
13.6 Latin America Liquid Biopsy Market Value Share Analysis, by End-user
13.7 Latin America Liquid Biopsy Market Forecast, by End-user
13.8 Latin America Liquid Biopsy Market Value Share Analysis, by Country
13.9 Latin America Liquid Biopsy Market Forecast, by Country
    13.9.1 Brazil
    13.9.2 Mexico
    13.9.3 Rest of LATAM
13.10 Latin America Liquid Biopsy Market Attractiveness Analysis
    13.10.1 By Country
    13.10.2 By Application
    13.10.3 By Circulating Biomarker
    13.10.3 By End-user

Section 14 Middle East & Africa (MEA) Liquid Biopsy Market Analysis
14.1 Middle East & Africa Liquid Biopsy Market Overview
14.2 Middle East & Africa Liquid Biopsy Market Value Share Analysis, by Application
14.3 Middle East & Africa Liquid Biopsy Market Forecast, by Application
    14.3.1 Middle East & Africa Liquid Biopsy Market Forecast, by Oncology
14.4 Middle East & Africa Liquid Biopsy Market Value Share Analysis, by Circulating Biomarker
14.5 Middle East & Africa Liquid Biopsy Market Forecast, by Circulating Biomarkers
14.6 Middle East & Africa Liquid Biopsy Market Value Share Analysis, by End-user
14.7 Middle East & Africa Liquid Biopsy Market Forecast, by End-user
14.8 Middle East & Africa Liquid Biopsy Market Value Share Analysis, by Country
14.9 Middle East & Africa Liquid Biopsy Market Forecast, by Country
    14.9.1 GCC
    14.9.2 South Africa
    14.9.3 Israel
    14.9.4 Rest of MEA
14.10 Middle East & Africa Liquid Biopsy Market Attractiveness Analysis
    14.10.1 By Country
    14.10.2 By Application
    14.10.3 By Circulating Biomarker
    14.10.4 By End-user

Section 15 Company Profiles
15.1 Competition Matrix
15.2 Company Profiles
    15.2.1 Biocept, Inc.
           15.2.1.1 Company Overview (HQ, Business Segments, Employee Strength)
           15.2.1.2 Financial Overview
           15.2.1.3 Product Portfolio
           15.2.1.4 SWOT Analysis
           15.2.1.5 Strategic Overview
    15.2.2 MDxHealth
           15.2.2.1 Company Overview (HQ, Business Segments, Employee Strength)
           15.2.2.2 Financial Overview
           15.2.2.3 Product Portfolio
           15.2.2.4 SWOT Analysis
           15.2.2.5 Strategic Overview
    15.2.3 Myriad Genetics, Inc.
           15.2.3.1 Company Overview (HQ, Business Segments, Employee Strength)
           15.2.3.2 Financial Overview
           15.2.3.3 Product Portfolio
           15.2.3.4 SWOT Analysis
           15.2.3.5 Strategic Overview
    15.2.4 Bio-Rad Laboratories
           15.2.4.1 Company Overview (HQ, Business Segments, Employee Strength)
           15.2.4.2 Financial Overview
           15.2.4.3 Product Portfolio
           15.2.4.4 SWOT Analysis
           15.2.4.5 Strategic Overview
    15.2.5 QIAGEN
           15.2.5.1 Company Overview (HQ, Business Segments, Employee Strength)
           15.2.5.2 Financial Overview
           15.2.5.3 Product Portfolio
           15.2.5.4 SWOT Analysis
           15.2.5.5 Strategic Overview
    15.2.6 F. Hoffmann-La Roche Ltd.
           15.2.6.1 Company Overview (HQ, Business Segments, Employee Strength)
           15.2.6.2 Financial Overview
           15.2.6.3 Product Portfolio
           15.2.6.4 SWOT Analysis
           15.2.6.5 Strategic Overview
    15.2.7 Thermo Fisher Scientific Inc.
           15.2.7.1 Company Overview (HQ, Business Segments, Employee Strength)
           15.2.7.2 Financial Overview
           15.2.7.3 Product Portfolio
           15.2.7.4 SWOT Analysis
           15.2.7.5 Strategic Overview
    15.2.8 Genomic Health, Inc.
           15.2.8.1 Company Overview (HQ, Business Segments, Employee Strength)
           15.2.8.2 Financial Overview
           15.2.8.3 Product Portfolio
           15.2.8.4 SWOT Analysis
           15.2.8.5 Strategic Overview
    15.2.9 Illumina, Inc.
           15.2.9.1 Company Overview (HQ, Business Segments, Employee Strength)
           15.2.9.2 Financial Overview
           15.2.9.3 Product Portfolio
           15.2.9.4 SWOT Analysis
           15.2.9.5 Strategic Overview

List of Tables

Table 01: Comparison of Liquid Biopsy and Tissue Biopsy: Practical Considerations
Table 02: Comparison of Different Classes of Circulating Biomarkers and their Potential for Liquid Biopsy
Table 03: Global Liquid Biopsy Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 04: Global Liquid Biopsy Market Value (US$ Mn) Forecast, by Oncology, 2016–2026
Table 05: Global Liquid Biopsy Market Value (US$ Mn) Forecast, by Circulating Biomarker, 2016–2026
Table 06: Global Liquid Biopsy Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 07: Global Liquid Biopsy Market Value (US$ Mn) Forecast, by Region, 2016–2026
Table 08: North America Liquid Biopsy Market Value (US$ Mn) Forecast, by Application, 2018–2026
Table 09: North America Liquid Biopsy Market Value (US$ Mn) Forecast, by Oncology, 2016–2026
Table 10: North America Liquid Biopsy Market Value (US$ Mn) Forecast, by Circulating Biomarkers, 2016–2026
Table 11: North America Liquid Biopsy Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 12: North America Liquid Biopsy Market Value (US$ Mn) Forecast, by Country, 2016–2026
Table 13: Europe Liquid Biopsy Market Value (US$ Mn) Forecast, by Application, 2018–2026
Table 14: Europe Liquid Biopsy Market Value (US$ Mn) Forecast, by Oncology, 2016–2026
Table 15: Europe Liquid Biopsy Market Value (US$ Mn) Forecast, by Circulating Biomarkers, 2016–2026
Table 16: Europe Liquid Biopsy Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 17: Europe Liquid Biopsy Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2016–2026
Table 18: Asia Pacific Liquid Biopsy Market Value (US$ Mn) Forecast, by Application, 2018–2026
Table 19: Asia Pacific Liquid Biopsy Market Value (US$ Mn) Forecast, by Oncology, 2016–2026
Table 20: Asia Pacific Liquid Biopsy Market Value (US$ Mn) Forecast, by Circulating Biomarkers, 2016–2026
Table 21: Asia Pacific Liquid Biopsy Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 22: Asia Pacific Liquid Biopsy Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2016–2026
Table 23: Latin America Liquid Biopsy Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 24: Latin America Liquid Biopsy Market Value (US$ Mn) Forecast, by Oncology, 2016–2026
Table 25: Latin America Liquid Biopsy Market Value (US$ Mn) Forecast, by Circulating Biomarker, 2016–2026
Table 26: Latin America Liquid Biopsy Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 27: Latin America Liquid Biopsy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 28: Middle East & Africa Liquid Biopsy Market Value (US$ Mn) Forecast, by Application, 2018–2026
Table 29: Middle East & Africa Liquid Biopsy Market Value (US$ Mn) Forecast, by Oncology, 2016–2026
Table 30: Middle East & Africa Liquid Biopsy Market Value (US$ Mn) Forecast, by Circulating Biomarkers, 2016–2026
Table 31: Middle East & Africa Liquid Biopsy Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 32: Middle East & Africa Liquid Biopsy Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2016–2026

List of Figures

Figure 01: Global Liquid Biopsy Market Snapshot
Figure 02: Global Liquid Biopsy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2026
Figure 03: Global Liquid Biopsy Market Value Share by Application (2017)
Figure 04: Global Liquid Biopsy Market Value Share by Circulating Biomarker (2017)
Figure 05: Global Liquid Biopsy Market Value Share by End-user (2017)
Figure 06: Global Liquid Biopsy Market Value Share by Region (2017)
Figure 07: Global Liquid Biopsy Market Value Share, by Application, 2017 and 2026
Figure 08: Global Liquid Biopsy Market Value Share, by Oncology, 2017 and 2026
Figure 09: Global Liquid Biopsy Market Revenue (US$ Mn) 9Forecast and Y-o-Y Growth (%) Projection, by Oncology, 2016–2026
Figure 10: Global Liquid Biopsy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by NIPT, 2016–2026
Figure 11: Global Liquid Biopsy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Transplant Diagnostics, 2016–2026
Figure 12: Global Liquid Biopsy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2016–2026
Figure 13: Global Liquid Biopsy Market Attractiveness, by Application
Figure 14: Global Liquid Biopsy Market Value Share Analysis, by Circulating Biomarker, 2017 and 2026
Figure 15: Global Liquid Biopsy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Circulating Tumor cells (CTC), 2016-2026
Figure 16: Global Liquid Biopsy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Free Nucleic Acid, 2016-2026
Figure 17: Global Liquid Biopsy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Extracellular Vesicles, 2016-2026
Figure 18: Global Liquid Biopsy Market Attractiveness Analysis, by Circulating Biomarker
Figure 19: Global Liquid Biopsy Market Value Share, by End-user, 2017 and 2026
Figure 20: Global Liquid Biopsy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospitals, 2018–2026
Figure 21: Global Liquid Biopsy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Reference Laboratories, 2018–2026
Figure 22: Global Liquid Biopsy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Academic and Research Institutes, 2018–2026
Figure 23: Global Liquid Biopsy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2018–2026
Figure 24: Global Liquid Biopsy Market Attractiveness, by End-user
Figure 25: Global Liquid Biopsy Market Value Share, by Region, 2017 and 2026
Figure 26: Global Liquid Biopsy Market Attractiveness, by Region, 2018–2026
Figure 27: North America Liquid Biopsy Market Value (US$ Mn) Forecast, 2016–2026
Figure 28: North America Liquid Biopsy Market Attractiveness Analysis, by Country
Figure 29: North America Liquid Biopsy Market Value Share Analysis, by Application, 2017 and 2026
Figure 30: North America Liquid Biopsy Market Value Share Analysis, by Circulating Biomarker, 2017 and 2026
Figure 31: North America Liquid Biopsy Market Value Share Analysis, by End-user, 2017 and 2026
Figure 32: North America Liquid Biopsy Market Value Share Analysis, by Country, 2017 and 2026
Figure 33: North America Liquid Biopsy Market Attractiveness Analysis, by Application, 2018–2026
Figure 34: North America Liquid Biopsy Market Attractiveness Analysis, by Circulating Biomarker, 2018–2026
Figure 35: North America Liquid Biopsy Market Attractiveness Analysis, by End-user, 2018–2026
Figure 36: Europe Liquid Biopsy Market Value (US$ Mn) Forecast, 2016–2026
Figure 37: Europe Market Liquid Biopsy Attractiveness Analysis, by Country/Sub-Region
Figure 38: Europe Liquid Biopsy Market Value Share Analysis, by Application, 2017 and 2026
Figure 39: Europe Liquid Biopsy Market Value Share Analysis, by Circulating Biomarker, 2017 and 2026
Figure 40: Europe Liquid Biopsy Market Value Share Analysis, by End-user, 2017 and 2026
Figure 41: Europe Liquid Biopsy Market Value Share Analysis, by Country/Sub-Region, 2017 and 2026
Figure 42: Europe Liquid Biopsy Market Attractiveness Analysis, by Application, 2018?2026
Figure 43: Europe Liquid Biopsy Market Attractiveness Analysis, by Circulating Biomarker, 2018?2026
Figure 44: Europe Liquid Biopsy Market Attractiveness Analysis, by End-user, 2018?2026
Figure 45: Asia Pacific Liquid Biopsy Market Value (US$ Mn) Forecast, 2016–2026
Figure 46: Asia Pacific Liquid Biopsy Market Attractiveness Analysis, by Country/Sub-Region
Figure 47: Asia Pacific Liquid Biopsy Market Value Share Analysis, by Application, 2017 and 2026
Figure 48: Asia Pacific Liquid Biopsy Market Value Share Analysis, by Circulating Biomarker, 2017 and 2026
Figure 49: Asia Pacific Liquid Biopsy Market Value Share Analysis, by End-user, 2017 and 2026
Figure 50: Asia Pacific Liquid Biopsy Market Value Share Analysis, by Country/Sub-Region, 2017 and 2026
Figure 51: Asia Pacific Liquid Biopsy Market Attractiveness Analysis, by Application, 2018?2026
Figure 52: Asia Pacific Liquid Biopsy Market Attractiveness Analysis, by Circulating Biomarker, 2018?2026
Figure 53: Asia Pacific Liquid Biopsy Market Attractiveness Analysis, by End-user, 2018?2026
Figure 54: Latin America Liquid Biopsy Market Value (US$ Mn) Forecast, 2016–2026
Figure 55: Latin America Market Attractiveness Analysis, by Country/Sub-region
Figure 56: Latin America Liquid Biopsy Market Value Share Analysis, by Application, 2017 and 2026
Figure 57: Latin America Liquid Biopsy Market Value Share Analysis, by Circulating Biomarker, 2017 and 2026
Figure 58: Latin America Liquid Biopsy Market Value Share Analysis, by End-user, 2017 and 2026
Figure 59: Latin America Liquid Biopsy Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
Figure 60: Latin America Liquid Biopsy Market Attractiveness Analysis, by Application, 2018-2026
Figure 61: Latin America Liquid Biopsy Market Attractiveness Analysis, by Circulating Biomarker, 2018-2026
Figure 62: Latin America Liquid Biopsy Market Attractiveness Analysis, by End-user, 2018-2026
Figure 63: Middle East & Africa Liquid Biopsy Market Value (US$ Mn) Forecast, 2016–2026
Figure 64: Middle East & Africa Market Attractiveness Analysis, by Country/Sub-Region
Figure 65: Middle East & Africa Liquid Biopsy Market Value Share Analysis, by Application, 2017 and 2026
Figure 66: Middle East & Africa Liquid Biopsy Market Value Share Analysis, by Circulating Biomarker, 2017 and 2026
Figure 67: Middle East & Africa Liquid Biopsy Market Value Share Analysis, by End-user, 2017 and 2026
Figure 68: Middle East & Africa Liquid Biopsy Market Value Share Analysis, by Country/Sub-Region, 2017 and 2026
Figure 69: Middle East & Africa Liquid Biopsy Market Attractiveness Analysis, by Application, 2018?2026
Figure 70: Middle East & Africa Liquid Biopsy Market Attractiveness Analysis, by Circulating Biomarker, 2018?2026
Figure 71: Middle East & Africa Liquid Biopsy Market Attractiveness Analysis, by End-user, 2018?2026

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

385

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved